Literature DB >> 69730

Biochemical and immunological characterization of the major envelope glycoprotein of bovine leukemia virus.

S G Devare, J R Stephenson.   

Abstract

The major envelope glycoprotein of bovine leukemia virus was isolated by lectin-bound Sepharose and DEAE-cellulose column chromatography. This protein was shown to have a molecular weight of about 41,000 and to lack detectable immunological cross-reactivity with glycoproteins of other oncornaviruses. Sera obtained from 100% of cattle examined with clinically diagnosed lymphosarcoma contained high-titered antibody to 125I-labeled bovine leukemia virus glycoprotein, whereas sera from animals in a disease-free herd were antibody negative.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 69730      PMCID： PMC515848          DOI： 10.1128/JVI.23.2.443-447.1977

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  19 in total

1.  PEDIGREE STUDIES IN BOVINE LYMPHOSARCOMA.

Authors:  J E CROSHAW; D A ABT; R R MARSHAK; W C HARE; J SWITZER; J IPSEN; R M DUTCHER
Journal:  Ann N Y Acad Sci       Date:  1963-11-04       Impact factor: 5.691

2.  Immunological cross reactivity of Mason-Pfizer monkey virus with type C RNA viruses endogenous to primates.

Authors:  J R Stephenson; S Hino; E W Garrett; S A Aaronson
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

3.  The purification of a gs antigen of the murine mammary tumor virus and its quantitation by radioimmunoassay.

Authors:  E Ritzi; A Baldi; S Spiegelman
Journal:  Virology       Date:  1976-11       Impact factor: 3.616

4.  Mason-Pfizer virus RNA genome: relationship to the RNA of morphologically similar isolates and other oncornaviruses.

Authors:  D Colcher; W Drohan
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

5.  Immunological characterization of a low molecular weight polypeptide of murine leukemia virus.

Authors:  S R Tronick; J R Stephenson; S A Aaronson
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

6.  Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30.

Authors:  H Ikeda; T Pincus; T Yoshiki; M Strand; J T August; E A Boyse; R C Mellors
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

7.  Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein.

Authors:  M Strand; J T August
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

8.  Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein.

Authors:  R A Steeves; M Strand; J T August
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

9.  Properties of mouse leukemia viruses. VIII. The major viral glycoprotein of Friend leukemia virus. Seroimmunological, interfering and hemagglutinating capacities.

Authors:  G Hunsmann; V Moennig; L Pister; E Seifert; W Schäfer
Journal:  Virology       Date:  1974-12       Impact factor: 3.616

10.  Bovine lymphosarcoma: development of a radioimmunologic technique for detection of the etiologic agent.

Authors:  S G Devare; J R Stephenson; P S Sarma; S A Aaronson; S Charder
Journal:  Science       Date:  1976-12-24       Impact factor: 47.728
View more
  13 in total

1.  Morphological revertants of an avian sarcoma virus-transformed mammalian cell line exhibit tumorigenicity and contain pp60src.

Authors:  A F Lau; R A Krzyzek; J S Brugge; R L Erikson; J Schollmeyer; A J Faras
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Bovine and ovine leukemia viruses. I. Characterization of viral antigens.

Authors:  W Rohde; G Pauli; J Paulsen; E Harms; H Bauer
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

3.  Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms.

Authors:  S J Anderson; M Furth; L Wolff; S K Ruscetti; C J Sherr
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

4.  Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.

Authors:  B Sola; P Avner; Y Sultan; C Jeanneau; P Maisonneuve
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  Primate retroviruses: envelope glycoproteins of endogenous type C and type D viruses possess common interspecies antigenic determinants.

Authors:  S G Devare; R E Hanson; J R Stephenson
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

6.  Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins.

Authors:  A S Khan; J R Stephenson
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

7.  Binding characteristics of wild mouse type C virus to mouse spinal cord and spleen cells.

Authors:  S Mohan; B K Pal
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems.

Authors:  J Ghysdael; R Kettmann; A Burny
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

9.  Evidence that the spontaneous blastogenesis of lymphocytes from bovine leukemia virus-infected cattle is viral antigen specific.

Authors:  R M Thorn; P Gupta; S J Kenyon; J F Ferrer
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Primate retroviruses: immunological cross-reactivity between major structural proteins of new and old world primate virus isolates.

Authors:  S G Devare; L O Arthur; D L Fine; J R Stephenson
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.